tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AVTX Stock Latest News

Avalo Therapeutics trading resumes
The FlyAvalo Therapeutics trading resumes
16d ago
AVTX
Avalo Therapeutics trading halted, volatility trading pause
PremiumThe Fly
Avalo Therapeutics trading halted, volatility trading pause
16d ago
AVTX
Avalo Therapeutics Shareholders Back Board and Strategies
PremiumCompany Announcements
Avalo Therapeutics Shareholders Back Board and Strategies
1M ago
8K
AVTX
Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
PremiumPress Releases
Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
1M ago
AVTX
Avalo Therapeutics sees cash runway into 2027
PremiumThe Fly
Avalo Therapeutics sees cash runway into 2027
1M ago
AVTX
Avalo Therapeutics reports Q2 EPS ($14.07) vs. ($140.73) last year
PremiumThe FlyAvalo Therapeutics reports Q2 EPS ($14.07) vs. ($140.73) last year
1M ago
AVTX
Avalo Therapeutics Welcomes New CMO with Competitive Package
Premium
Company Announcements
Avalo Therapeutics Welcomes New CMO with Competitive Package
2M ago
8K
AVTX
Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
Premium
Press Releases
Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
2M ago
AVTX
Avalo Therapeutics appoints Doyle as Chief Medical Officer
PremiumThe Fly
Avalo Therapeutics appoints Doyle as Chief Medical Officer
2M ago
AVTX
Avalo Therapeutics announces active IND for AVTX-009
PremiumThe Fly
Avalo Therapeutics announces active IND for AVTX-009
2M ago
AVTX
Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
PremiumPress Releases
Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1β mAb, to Treat Hidradenitis Suppurativa
2M ago
AVTX
Avalo Therapeutics Welcomes New Chief Legal Officer Paul Varki
PremiumCompany Announcements
Avalo Therapeutics Welcomes New Chief Legal Officer Paul Varki
3M ago
8K
AVTX
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
PremiumPress ReleasesAvalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
3M ago
AVTX
Avalo Therapeutics announces Paul Varki joins as Chief Legal Officer
Premium
The Fly
Avalo Therapeutics announces Paul Varki joins as Chief Legal Officer
3M ago
AVTX
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
Premium
Press Releases
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
3M ago
AVTX
Avalo Therapeutics files to sell 22.36M shares of common stock for holders
PremiumThe Fly
Avalo Therapeutics files to sell 22.36M shares of common stock for holders
4M ago
AVTX
Avalo Therapeutics expects cash to fund operations into 2027
PremiumThe Fly
Avalo Therapeutics expects cash to fund operations into 2027
4M ago
AVTX
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
PremiumPress Releases
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
4M ago
AVTX
Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks
PremiumStock Analysis & Ideas
Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks
5M ago
ANGO
AVTX
Oppenheimer more bullish on Avalo Therapeutics, upgrades to Outperform
PremiumThe FlyOppenheimer more bullish on Avalo Therapeutics, upgrades to Outperform
5M ago
LLY
AVTX
Avalo Therapeutics upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
Avalo Therapeutics upgraded to Outperform from Perform at Oppenheimer
5M ago
AVTX
Avalo Therapeutics appoints Kantoff, Goldman, Truex as independent directors
Premium
The Fly
Avalo Therapeutics appoints Kantoff, Goldman, Truex as independent directors
6M ago
AVTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >